Open main menu

Psychiatrienet β

Difference between revisions of "Citalopram-amitriptyline"

 
(12 intermediate revisions by 5 users not shown)
Line 1: Line 1:
 
{{Drugswitch
 
{{Drugswitch
| from = (es)citalopram
+
| from = citalopram
 
| to = amitriptyline
 
| to = amitriptyline
 
| stop =  
 
| stop =  
* '''Day 0:''' gradually reduce dosage of citalopram/escitalopram to a maximum of 20 mg/ day resp. 10 mg/day, when this dosage is respectively > 20 mg/day and > 10 mg/day.
+
{{TCAdecrease25p3d}}
* '''Day 1:''' stop administration of citalopram/escitalopram.
 
 
 
 
| start =  
 
| start =  
* '''Day 1:''' no wash-out period is needed. Start administration of amitriptyline in a low dosage of 25-50 mg/day.
+
{{TCAincrease25p3d}}
* Start low, go slow!
 
 
| info =
 
| info =
* The same applies to [[escitalopram]].
+
{{TCAplasmalevelmonitoring}}
 
}}
 
}}

Latest revision as of 12:39, 30 June 2023

Citalopram
Type Antidepressant
Group SSRI
links
ATC-code N06AB04
Medscape Citalopram
PubChem 2771
PubMed Citalopram
Kompas (Dutch) citalopram
Wikipedia citalopram
Amitriptyline
Type Antidepressant
Group TCA
links
ATC-code N06AA09
Medscape Amitriptyline
PubChem 2160
PubMed Amitriptyline
Kompas (Dutch) Amitriptyline
Wikipedia Amitriptyline

Switch medication from citalopram to amitriptyline.[1] [2]

Nietinrijdenbord.png Stop citalopram
  • Day 1: Decrease with about 25% of the original dose per 3 days.
Eenrichtingbord.png Start amitriptyline
  • Day 1: Increase with about 25% of target dose per 3 days.
Infobord.png More information
  • Plasma monitoring for TCA's is advisable, because of plasma-reponse relations, genetic polymorphism and under or overdosing.[3]
  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
  3. (dutch) monografie.org tricyclische-antidepressiva
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.